PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer
文献类型:期刊论文
作者 | Zhang, Xinxin1,2![]() ![]() |
刊名 | JOURNAL OF PHARMACY AND PHARMACOLOGY
![]() |
出版日期 | 2008-08 |
卷号 | 60期号:8页码:1077-1087 |
ISSN号 | 0022-3573 |
DOI | 10.1211/jpp.60.8.0014 |
文献子类 | Article |
英文摘要 | Most drugs do not have the pharmacokinetic features required for optimal pulmonary delivery. In this study, we developed PEGylated nanostructured lipid carriers (PEG-NLCs) to improve the delivery of anti-tumour agents to lung tumours. PEG-40 NLCs modified with PEG-40 stearate (molecular weight 2000 Da), PEG-100 NLCs modified with PEG-100 stearate (molecular weight 5000 Da) and NLCs without PEG modification were prepared by melt-emulsification and homogenization, and were loaded with 10-hydroxycamptothecin (HCPT). They were investigated in terms of physiological characteristics, biodistribution, cellular uptake, and anti-tumour effect in-vivo. PEG-NLCs exhibited regular morphology, with a spherical shape. The particle size (measured by laser diffraction) was approximately 100 nm. Encapsulation in PEG-NLCs protected the active lactone form of HCPT compared with HCPT solution after incubation with plasma. In biodistribution studies, PEG-NLCs, especially PEG-40 NLCs, had longer circulation time and decreased uptake by the reticuloenclothelial system (RES) compared with unmodified NLCs. PEG-NLCs accumulated in the lungs after i.v. injection in mice. PEG-NLCs showed enhanced cellular uptake by human lung adenocarcinoma epithelial A549 cells. In-vivo experiments indicated that PEG-NLCs loaded with HCPT have superior efficacy against A549 lung cancer compared with HCPT solution and NLCs. These results suggest that PEG-NLCs is a promising delivery system for HCPT in the treatment of lung cancer. |
WOS关键词 | POLYETHYLENEGLYCOL-COATED LIPOSOMES ; PROTEIN SURFACE INTERACTIONS ; VASCULAR-PERMEABILITY ; NANOPARTICLES ; SYSTEM ; TUMOR ; SIZE ; DELIVERY ; CELLS ; OXIDE |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000257834800014 |
出版者 | WILEY-BLACKWELL |
源URL | [http://119.78.100.183/handle/2S10ELR8/272858] ![]() |
专题 | 药物制剂研究中心 |
通讯作者 | Pan, Weisan |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China 2.Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China; |
推荐引用方式 GB/T 7714 | Zhang, Xinxin,Gan, Yong,Gan, Li,et al. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY,2008,60(8):1077-1087. |
APA | Zhang, Xinxin,Gan, Yong,Gan, Li,Nie, Shufang,&Pan, Weisan.(2008).PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.JOURNAL OF PHARMACY AND PHARMACOLOGY,60(8),1077-1087. |
MLA | Zhang, Xinxin,et al."PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer".JOURNAL OF PHARMACY AND PHARMACOLOGY 60.8(2008):1077-1087. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。